Ishikawa S, Kobayashi I, Hamada J, Tada M, Hirai A, Furuuchi K, Takahashi Y, Ba Y, Moriuchi T
Institute for Genetic Medicine Hokkaido University, Division of Cancer-Related Genes, 060-0815, Sapporo, Japan.
Gene. 2001 Apr 4;267(1):101-10. doi: 10.1016/s0378-1119(01)00378-x.
AIE-75 is a protein identified as an autoantigen in patients with autoimmune enteropathy and as a colon cancer-related antigen. It has recently been assigned to be a causative gene for Usher type 1C congenital syndromic hearing loss. The novel protein has three PSD-95/Dlg/ZO-1 (PDZ) protein-protein interaction domains and is therefore implicated to function as a molecular anchor or sorter. We have identified a novel protein that binds to AIE-75 by yeast two-hybrid screening. The protein has a high homology to the tumor suppressor MCC (mutated in colon cancer; or MCC1 hereafter) and was named MCC2. MCC2 protein binds the first PDZ domain of AIE-75 with its C-terminal amino acids -DTFL. Since the MCC1 does not bind to AIE-75 and the MCC2 displays different expression patterns in various organs compared to MCC1, they appear to play distinct roles in cells. The MCC2 gene is located on chromosome 19p13 in the vicinity of APCL gene, while MCC1 maps near to APC tumor suppressor gene. Because of negative expression of MCC2 in a panel of cancer cell-lines compared to the corresponding normal tissues, we suggest that further study is necessary to investigate a possible role of MCC2 as a tumor suppressor.
AIE-75是一种蛋白质,在自身免疫性肠病患者中被鉴定为自身抗原,同时也是一种与结肠癌相关的抗原。最近它被确定为1C型Usher先天性综合征性听力损失的致病基因。这种新型蛋白质具有三个PSD-95/Dlg/ZO-1(PDZ)蛋白-蛋白相互作用结构域,因此被认为具有分子锚或分选器的功能。我们通过酵母双杂交筛选鉴定出一种与AIE-75结合的新型蛋白质。该蛋白质与肿瘤抑制因子MCC(在结肠癌中发生突变,以下简称MCC1)具有高度同源性,并被命名为MCC2。MCC2蛋白通过其C末端氨基酸-DTFL与AIE-75的第一个PDZ结构域结合。由于MCC1不与AIE-75结合,且与MCC1相比,MCC2在各个器官中表现出不同的表达模式,它们似乎在细胞中发挥着不同的作用。MCC2基因位于19号染色体p13上APCL基因附近,而MCC1则位于APC肿瘤抑制基因附近。由于与相应的正常组织相比,MCC2在一组癌细胞系中呈阴性表达,我们建议有必要进一步研究MCC2作为肿瘤抑制因子的可能作用。